New study tracks brain fog in kids after stem cell transplants

NCT ID NCT04937400

Ongoing Knowledge-focused Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows over 1,000 children aged 0-21 who are getting stem cell transplants. Researchers will check for delirium twice a day during their hospital stay. The goal is to learn how often delirium happens, what raises the risk, and how it affects recovery. This information could help doctors find better ways to prevent or manage delirium in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better predict and prevent delirium in children after stem cell transplants, improving recovery.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test any drug or intervention, so it may not lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DELIRIUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

delirium disease related to hematopoietic stem cell transplant

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DELIRIUM STEM CELL TRANSPLANT COMPLICATIONS

Contacts and locations

Locations

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States
Dana Farber Cancer Center

Boston, Massachusetts, 02215, United States
Hospital for Sick Children

Toronto, Ontario, Canada
St Jude Children's Research Hospital

Memphis, Tennessee, 38105, United States
University of California San Francisco

San Francisco, California, 94143, United States
Weill Cornell Medical College

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.